Rhythm Pharmaceuticals公布探索性第二阶段试验的初步数据,显示Setmelanotide在Prader-Willi综合症中展现了积极的疗效信号

美股速递
Dec 11, 2025

Rhythm Pharmaceuticals公布探索性第二阶段试验的初步数据,显示Setmelanotide在Prader-Willi综合症中展现了积极的疗效信号。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10